Microbial Sharing between Pediatric Patients and Therapy Dogs during Hospital Animal-Assisted Intervention Programs.
animal-assisted interventions
hospital-associated pathogens
microbiome
patient safety
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
13 May 2021
13 May 2021
Historique:
received:
07
04
2021
revised:
06
05
2021
accepted:
11
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Microbial sharing between humans and animals has been demonstrated in a variety of settings. However, the extent of microbial sharing that occurs within the healthcare setting during animal-assisted intervention programs is unknown. Understanding microbial transmission between patients and therapy dogs can provide important insights into potential health benefits for patients, in addition to addressing concerns regarding potential pathogen transmission that limits program utilization. This study evaluated for potential microbial sharing between pediatric patients and therapy dogs and tested whether patient-dog contact level and a dog decolonization protocol modified this sharing. Patients, therapy dogs, and the hospital environment were sampled before and after every group therapy session and samples underwent 16S rRNA sequencing to characterize microbial communities. Both patients and dogs experienced changes in the relative abundance and overall diversity of their nasal microbiome, suggesting that the exchange of microorganisms had occurred. Increased contact was associated with greater sharing between patients and therapy dogs, as well as between patients. A topical chlorhexidine-based dog decolonization was associated with decreased microbial sharing between therapy dogs and patients but did not significantly affect sharing between patients. These data suggest that the therapy dog is both a potential source of and a vehicle for the transfer of microorganisms to patients but not necessarily the only source. The relative contribution of other potential sources (e.g., other patients, the hospital environment) should be further explored to determine their relative importance.
Identifiants
pubmed: 34068292
pii: microorganisms9051054
doi: 10.3390/microorganisms9051054
pmc: PMC8153335
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NICHD NIH HHS
ID : R01 HD097692
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL141589
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH0008428
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI144561
Pays : United States
Références
PLoS One. 2015 Jul 02;10(7):e0131468
pubmed: 26134411
Microbiome. 2014 Jan 28;2(1):1
pubmed: 24468033
Microbiome. 2015 Jan 23;3:2
pubmed: 25705378
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Front Vet Sci. 2019 Jun 04;6:167
pubmed: 31214606
J Am Vet Med Assoc. 2009 Jun 1;234(11):1404-17
pubmed: 19480620
Microbiome. 2015 Oct 13;3:49
pubmed: 26459172
JAMA Pediatr. 2015 Nov;169(11):e153219
pubmed: 26523822
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5786-E5795
pubmed: 29871947
J Vet Dent. 2016 Jun;33(2):97-107
pubmed: 28326980
Front Microbiol. 2019 Oct 23;10:2407
pubmed: 31708888
Complement Ther Clin Pract. 2020 May;39:101145
pubmed: 32379677
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
J Dev Behav Pediatr. 2018 Sep;39(7):580-590
pubmed: 29994814
Science. 2012 Aug 31;337(6098):1115-9
pubmed: 22837383
Microb Drug Resist. 2018 May;24(4):434-446
pubmed: 28922060
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Genome Biol. 2014;15(12):550
pubmed: 25516281
Complement Ther Med. 2014 Apr;22(2):371-90
pubmed: 24731910
PLoS One. 2015 Mar 02;10(3):e0118207
pubmed: 25729898
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Sci Total Environ. 2017 Mar 1;581-582:750-755
pubmed: 28063655
Complement Ther Clin Pract. 2018 Nov;33:49-55
pubmed: 30396626
Zoonoses Public Health. 2012 Jun;59(4):286-93
pubmed: 22233337
N Engl J Med. 2016 Aug 4;375(5):411-421
pubmed: 27518660
Allergy Asthma Clin Immunol. 2013 Apr 22;9(1):15
pubmed: 23607879
Trends Mol Med. 2015 Jul;21(7):427-32
pubmed: 25907678
Eur J Integr Med. 2016 Oct;8(5):695-706
pubmed: 32362955
Animals (Basel). 2020 Apr 27;10(5):
pubmed: 32349351
Nat Commun. 2017 Nov 27;8(1):1814
pubmed: 29180750
Elife. 2013 Apr 16;2:e00458
pubmed: 23599893
Microbiome. 2017 Apr 6;5(1):40
pubmed: 28381231
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471058
J Allergy Clin Immunol. 2011 Oct;128(4):880-885.e4
pubmed: 21820714
PLoS One. 2016 Aug 10;11(8):e0160331
pubmed: 27509169
Nat Rev Microbiol. 2011 Apr;9(4):244-53
pubmed: 21407241
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Sci Rep. 2013;3:1413
pubmed: 23475210
PLoS One. 2014 Jan 08;9(1):e83197
pubmed: 24421875
J Allergy Clin Immunol. 2009 Oct;124(4):745-50.e4
pubmed: 19703709
Antimicrob Resist Infect Control. 2020 Jun 1;9(1):78
pubmed: 32487220
Wien Klin Wochenschr. 2009;121(3-4):86-90
pubmed: 19280131
ISME J. 2011 Apr;5(4):639-49
pubmed: 20962874
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
PLoS One. 2018 Feb 23;13(2):e0193411
pubmed: 29474439